» Articles » PMID: 32064458

Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment

Overview
Specialty Oncology
Date 2020 Feb 18
PMID 32064458
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer-related cognitive impairment (CRCI) is a concerning problem for many cancer survivors. Evaluating patients for CRCI has been a challenge, in part because of a lack of standardized practices. Self-report instruments are often used to assess CRCI, but there are no validated cutpoints. We present the results of receiver operating characteristic curve analysis identifying cutpoints of the Functional Assessment of Cancer Therapy-Cognition perceived cognitive impairment (PCI) in female breast cancer survivors for identifying CRCI cases. We defined presence of CRCI based on elevated complaints on the Patient's Assessment of Own Functioning Inventory compared with healthy control scores. Our results indicate that scores less than 54 in PCI scores using 18 items and scores less than 60 in PCI scores using 20 items exhibited good ability to discriminate CRCI cases from noncases (area under the receiver operating characteristic curve was 0.84 [95% CI = 0.73 to 0.94]). These preliminary results represent an important contribution toward standardizing practices across CRCI studies.

Citing Articles

Fear of Cancer Recurrence Associated with Perceived Cognitive Impairment among Women with Cancers: Findings from the Women's Health Initiative Life and Longevity After Cancer Study.

Yang Y, McLaughlin E, Naughton M, Von Ah D, Saquib N, Carroll J Prev Oncol Epidemiol. 2025; 1(1).

PMID: 39831265 PMC: 11739934. DOI: 10.1080/28322134.2023.2292359.


Patients' and clinicians' knowledge in cancer-related cognitive impairment and its implications: current perspective.

Ferrari M, Conti L, Capetti B, Marzorati C, Grasso R, Pravettoni G Future Oncol. 2024; 20(40):3569-3578.

PMID: 39530545 PMC: 11776859. DOI: 10.1080/14796694.2024.2421148.


Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer.

Henneghan A, Van Dyk K, Haywood D, Patel M, Franco-Rocha O, Bang S Breast Cancer Res Treat. 2024; 209(1):125-138.

PMID: 39269553 DOI: 10.1007/s10549-024-07479-4.


The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment.

Janelsins M, Van Dyk K, Hartman S, Koll T, Cramer C, Lesser G J Natl Cancer Inst. 2024; 117(2):217-228.

PMID: 39250738 PMC: 11807440. DOI: 10.1093/jnci/djae209.


Cognitive-enhanced eHealth psychosocial stepped intervention for managing breast cancer-related cognitive impairment: Protocol for a randomized controlled trial.

Serra-Blasco M, Souto-Sampera A, Medina J, Flix-Valle A, Ciria-Suarez L, Arizu-Onassis A Digit Health. 2024; 10:20552076241257082.

PMID: 39070895 PMC: 11273701. DOI: 10.1177/20552076241257082.


References
1.
Van Dyk K, Ganz P . Doctor, Now That My Chemotherapy Treatment Is Over, When Will My "Chemofog" Lift?. J Clin Oncol. 2016; 35(5):482-484. DOI: 10.1200/JCO.2016.70.7497. View

2.
Van Dyk K, Crespi C, Bower J, Castellon S, Petersen L, Ganz P . The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment. Cancer. 2018; 125(5):681-689. PMC: 6378114. DOI: 10.1002/cncr.31858. View

3.
Costa D, Loh V, Birney D, Dhillon H, Fardell J, Gessler D . The Structure of the FACT-Cog v3 in Cancer Patients, Students, and Older Adults. J Pain Symptom Manage. 2018; 55(4):1173-1178. DOI: 10.1016/j.jpainsymman.2017.12.486. View

4.
Janelsins M, Heckler C, Peppone L, Kamen C, Mustian K, Mohile S . Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. J Clin Oncol. 2016; 35(5):506-514. PMC: 5455314. DOI: 10.1200/JCO.2016.68.5826. View

5.
Ganz P, Kwan L, Castellon S, Oppenheim A, Bower J, Silverman D . Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 2013; 105(11):791-801. PMC: 3672076. DOI: 10.1093/jnci/djt073. View